- Report
- September 2025
- 250 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- September 2025
- 250 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- September 2025
- 250 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- April 2025
- 200 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- April 2025
- 200 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- February 2025
- 200 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- January 2025
- 200 Pages
Global
From €3952EUR$4,490USD£3,448GBP
- Report
- January 2026
- 274 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Report
- January 2026
- 138 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Report
- January 2026
- 377 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Report
- January 2026
- 377 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Report
- January 2026
- 173 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Report
- January 2026
- 465 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Report
- January 2026
- 196 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Report
- January 2026
- 279 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Report
- January 2026
- 178 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Report
- January 2026
- 427 Pages
Global
From €5150EUR$5,850USD£4,492GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2641EUR$3,000USD£2,304GBP
- Drug Pipelines
- April 2025
- 204 Pages
Global
From €2641EUR$3,000USD£2,304GBP
- Report
- May 2025
- 114 Pages
Global
From €4181EUR$4,750USD£3,647GBP

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more